Objective-Bariatric surgery is emerging as an effective method to alleviate a multitude of medical conditions associated with morbid obesity and type 2 diabetes. However, little is known about the effects and mechanisms of bariatric surgery on visceral fat inflammation and endothelial dysfunction in type 2 diabetes. We hypothesize that bariatric surgery ameliorates interferon-␥-mediated adipose tissue inflammation/oxidative stress and improves endothelial function in type 2 diabetic mice. Methods and Results-Control mice (m Lepr db ) and diabetic mice (Lepr db ) were treated with either sham surgery or improved gastric bypass surgery and then were evaluated at 5, 10, 20, and 30 days to assess postsurgical effects. Surgery reduced body weight, abdominal adiposity, blood glucose level, and food intake in Lepr db . The surgery-induced decrease in visceral adiposity was accompanied by amelioration of T-lymphocytes and macrophage infiltration, as well as reduction in the expression of interferon-␥ and other inflammatory cytokines in the mesenteric adipose tissue (MAT) of Lepr db mice. Furthermore, surgery improved endothelium-dependent, but not endothelium-independent, vasorelaxation in small mesenteric arteries (SMA) of Lepr db mice. The improvement in endothelial function was largely attenuated by nitric oxide synthase inhibitor (L-NAME) incubation. Interferon-␥ treatment increased the mRNA expression of tumor necrosis factor-␣ in the MAT of control mice and incubation of SMA of control mice with tumor necrosis factor-␣ caused impairment of endothelial function. Superoxide production in MAT/SMA and nitrotyrosine protein level in SMA were elevated in diabetic mice. Surgery reduced MAT/SMA oxidative stress in Lepr db mice. Conclusion-The amelioration of adipose tissue inflammation and the improvement of endothelial function may represent important mechanisms that result in cardiovascular benefits after bariatric surgery. (Arterioscler Thromb Vasc Biol.
O besity and diabetes are becoming pandemic and pose a major risk for a number of comorbidities, including cardiovascular diseases. 1 Morbid obesity remains largely refractory to diet, exercise, and medication, but it generally responds well to bariatric surgery. [2] [3] [4] [5] [6] [7] Bariatric surgery demonstrates the most encouraging results in the treatment of patients with morbid obesity and type 2 diabetes by effectively reducing body weight and profoundly improving insulin sensitivity. 8 -14 Moreover, a substantial majority of obese patients with diabetes, hypertension, and other cardiovascular complications experience complete resolution or improvement. 3 Importantly, endothelium-dependent vasodilatory function was enhanced after gastric bypass surgery in morbidly obese patients with type 2 diabetes, 11, 15 but the mechanism by which bariatric surgery improves endothelial function in morbidly obese and diabetic patients has yet to be clearly elucidated.
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Macrophage infiltration and chemoattractant gene expression were reduced in white adipose tissue of morbidly obese subjects after gastric bypass surgery-induced weight loss. 16 Among various cytokines produced by activated macrophages, tumor necrosis factor-␣ (TNF-␣) is a key proinflammatory cytokine involved in the pathogenesis and progression of cardiovascular dysfunction 17 by stimulating vascular oxidative stress, 18 enhancing endothelial permeability, 19 promoting inflammation, 18 and potentiating vasoconstriction. 20 As a hallmark cytokine of T-lymphocyte, interferon-gamma (IFN-␥) plays a critical role in the regulation of adipose tissue inflammation and enhances the production of various inflammatory cytokines, including TNF-␣, in cultured adipose tissue. 21 Within this context, the purpose of this study was to examine the effects of bariatric surgery on IFN-␥-induced visceral adipose tissue inflammation/oxidative stress and endothelial dysfunction in type 2 diabetic mice.
Subjects and Methods

Animals
The procedures followed were in accordance with approved guidelines set by the Animal Care Committee at the University of Missouri. Heterozygote control mice (m Lepr db ; background strain, C57BLKS/J) and homozygote type 2 diabetic mice (Lepr db ; background strain, C57BLKS/J) were purchased from Jackson Laboratory (Bar Harbor, ME) and maintained on a normal rodent chow diet. Male, 20-to 35-gram m Lepr db and 40-to 60-g Lepr db mice were used in this study. The m Lepr db were treated with murine recombinant IFN-␥ (330 g/kg/d, intraperitoneal injection, 5 days; R&D) at the age of 12 to 16 weeks. 22
Improved Gastric Bypass Surgery
Improved gastric bypass surgery (IGBS) was performed using a modified surgical method that mimics the traditional Roux-en-Y gastric bypass surgery 23 (Supplemental Figure I available online at http://atvb.ahajournals.org). Mice were anesthetized with sodium pentobarbital (50 mg/kg intraperitoneal injection). The stomach and small intestine were exposed from the abdominal cavity, 15 cm away from Treitz ligament, and prepared for anastomosis. The small intestine and large curve of the stomach were anastomosed with 6-0 silk suture side-to-side. The pylorus was separated and the 2 parts of the pylorus were dissected and closed. In the sham surgery, the abdominal cavity was opened, but no further surgical procedures were performed. At age 12 weeks, m Lepr db and Lepr db mice were treated with either sham surgery or IGBS. Lepr db mice were assessed 5, 10, 20, and 30 days after IGBS (P5, P10, P20, and P30) or 20 days after sham surgery. The m Lepr db mice were assessed 20 days after either sham surgery or IGBS.
Experimental Design
IFN-␥, MCP-1, and nitrotyrosine protein expression were determined by Western blotting. The mRNA expressions of CD3, CD68, IFN-␥, monocyte chemoattractant protein-1 (MCP-1), and so on, were examined by quantitative reverse-transcription polymerase chain reaction. Immunohistochemistry was used to examine mesenteric adipose tissue (MAT) accumulation of CD3-positive T-lymphocytes, Mac-3, or F4/80-positive macrophages. Electron paramagnetic resonance spectroscopy was used to determine the superoxide production in both MAT and small mesenteric arteries (SMA). Isolated SMA responses were studied using wire Myograph. The expanded Methods section can be found in the online data supplement.
Data Analysis
All data were presented as meanϮSEM, except as specifically stated. Statistical comparisons were performed with 2-way ANOVA for vasomotor responses under various treatments, and with 1-way ANOVA for other data. Intergroup differences were tested with Fisher's least significant difference test inequality. Significance was accepted at PϽ0.05.
Results
Bariatric Surgery Reduced Body Weight and Adiposity and Improved Glycemic Control
The effects of bariatric surgery on weight loss and glycemic control were examined. We note that 5, 10, 20, and 30 days after surgery in mice are equivalent to 0.5, 1, 2, and 3 years after surgery in human beings. Our results revealed rapid weight loss and decrease in body fat mass by day 5 after surgery, and the body weight and body fat mass continued to decrease at days 10, 20, and 30 after surgery (Supplemental Table I ). Surgery also reduced abdominal adiposity by decreasing abdominal girth, mesenteric bed weight, and MAT adipocyte size in diabetic mice (Supplemental Table II ). The food intake decreased by 15% to 25% in diabetic mice after surgery ( Supplemental Table I ).
Adiponectin level was lower in the serum of Lepr db mice, and surgery increased serum adiponectin levels (Supplemental Figure II ).
Bariatric surgery also exerted profound effects on glycemic control and metabolism. IGBS significantly decreased blood glucose level as early as 5 days after surgery, and the blood glucose level continued to decrease at 10 and 20 days after surgery. Within 20 days after surgery, glucose had a parallel evolution to weight, abdominal girth, and fat mass; however, at 30 days after surgery, we noted a slight but nonsignificant increase in glucose level (Supplemental Table I ).
The Effects of Bariatric Surgery on Adipose Tissue Inflammatory Cell Infiltration and Inflammatory Cytokine Expression
CD3 is the marker of T-lymphocytes. The CD3-positive T-lymphocyte infiltration was increased in the MAT of diabetic mice. The mRNA expression of CD3 was also higher in the MAT of diabetic mice. Bariatric surgery reduced MAT CD3-positive T-lymphocytes infiltration as well as CD3 mRNA expression ( Figure 1A, B) . IFN-␥ is the hallmark cytokine of T-lympohcytes. The mRNA and protein expression of IFN-␥ were elevated in the MAT of diabetic mice. Bariatric surgery reduced MAT expression of IFN-␥ in diabetic mice but not in control mice ( Figure  1C, D) .
Mac-3, CD68, and F4/80 are the markers of macrophages. The Mac-3 or F4/80-positive macrophage infiltration and CD68 mRNA expression were higher in MAT of diabetic mice vs control mice. Bariatric surgery reduced macrophage accumulation in MAT of diabetic mice (Figure 2A , B, and Supplemental Figure III ). MCP-1 is mainly produced by macrophages. The mRNA and protein expression of MCP-1 were higher in diabetic mice vs control mice. Bariatric surgery ameliorated the mRNA and protein expression of MCP-1 in MAT of diabetic mice (Figure 2C, D) . Additionally, the mRNA expression of other macrophage-derived inflammatory cytokines, such as TNF-␣, macrophage inflammatory protein-1alpha (MIP-1␣), and MIP-1␤, were also increased in diabetic mice. Bariatric surgery inhibited MAT TNF-␣, MIP-1␣, and MIP-1␤ mRNA expression (Supplemental Figure IV) .
The Effects of Bariatric Surgery on SMA Endothelial Function
Acetylcholine-induced endothelium-dependent vasorelaxation was impaired in SMA of diabetic mice vs control mice. Bariatric surgery improved endothelial function of diabetic mice (Figure 3 ). Sodium nitroprusside-induced endotheliumindependent vasorelaxation and phenylephrine-induced vasoconstriction were comparable among groups (Supplemental Figures V and VI) . Nitric oxide synthase inhibitor (L-NAME) incubation largely attenuated the surgery-induced improvement of endothelial function in diabetic mice (Figure 4 ). Despite the profound effects of bariatric surgery on improving endothelial function of diabetic mice, bariatric surgery affected neither the endothelium-dependent nor the endothelium-independent vasorelaxation in nondiabetic control mice (Supplemental Figure VII) .
The m Lepr db mice treated with recombinant IFN-␥ showed significantly increased TNF-␣ mRNA expression in MAT ( Figure 5A ). Incubation of SMA with 10 ng/mL of recombinant TNF-␣ impaired endothelial function of SMA in the m Lepr db mice ( Figure 5B ).
The Effects of Bariatric Surgery on MAT/SMA Oxidative Stress
The superoxide level was elevated in both MAT and SMA of diabetic mice. Bariatric surgery reduced superoxide production in diabetic mice without affecting that in control mice ( Figure 6A, B) . Furthermore, the nitrotyrosine protein expres- sion in SMA was higher in diabetic mice vs control mice. Bariatric surgery decreased SMA nitrotyrosine protein expression ( Figure 6C ).
Discussion
Bariatric surgical procedures have increased exponentially in the United States 24 and animal models are increasingly being used in the study of bariatric surgery to examine the underlying mechanisms of the therapeutic effects. 25 How-ever, no studies to date have examined the effects of bariatric surgery in the type 2 diabetic murine model. We modified the work of Troy et al 23 to establish the IGBS method in murine model of type 2 diabetes; this allows the study of mechanisms responsible for the therapeutic effects of bariatric surgery in morbid obesity and type 2 diabetes. The major findings in this study are that bariatric surgery leads to rapid weight loss, reduces whole body and abdominal adiposity, and improves glycemic control; bariatric surgery serves as an effective anti-inflammatory strategy by ameliorating IFN-␥-mediated adipose tissue inflammation; and bariatric surgery reverses endothelial dysfunction by improving nitric oxide availability and inhibiting vascular oxidative stress.
Bariatric Surgery Serves as a Successful Anti-Inflammatory Strategy
Obesity-related chronic inflammation is implicated in the pathogenesis of type 2 diabetes. 26 Previous studies demonstrated that long-term weight loss after bariatric surgery is accompanied by a decreased proinflammatory state. Bariatric surgery decreased circulating levels of C-reactive protein, [27] [28] [29] [30] IL-6, 29 serum amyloid A, [31] [32] and leptin, 8 but increased the circulating level of adiponectin. 8 Bariatric surgery also reduced subcutaneous adipose tissue macrophage attraction and gene expression of inflammatory cytokines, such as TNF-␣ and IL-6. 16, 29 Compared with subcutaneous fat, visceral fat showed a higher transcript level of IFN-␥ and a broader leukocytosis that included macrophages, T cells, and natural killer cells. 33 Our murine model of IGBS allowed us to examine the effects of bariatric surgery on the inflammatory status of MAT. Our results showed that bariatric surgery reduced T-lymphocyte and macrophage infiltration, as well as the expression of IFN-␥, MCP-1, TNF-␣, MIP-1␣, and MIP-1␤ in MAT of diabetic mice. Thus, surgery-induced weight loss is accompanied by reduced adipose tissue inflammation, and bariatric surgery serves as a successful anti-inflammatory strategy in type 2 diabetes.
The Association Between Adipose Tissue Inflammation and Endothelial Dysfunction
Increased adipose tissue inflammation in type 2 diabetes reflects the positive association between cardiovascular diseases and diabetes. 34 An abdominal fat pattern, as determined by an increased waist-to-hip ratio and visceral fat diameter, was the sole significant predictor of flowmediated vasodilation in overweight adults, 10, 35 suggesting the link between visceral adiposity and vascular dysfunction. 36, 37 The mechanisms whereby excessive visceral fat depot leads to deterioration of vascular health are complex. Adipose tissue-derived inflammatory cytokines may serve as mechanisms linking adipose tissue inflammation and endothelial dysfunction. 34 As an important adipose-derived proinflammatory mediator, TNF-␣ plays a key role in endothelial dysfunction associated with ischemia reperfusion injury, 38, 39 obesity, 40 and diabetes. 41 In type 2 diabetic mice, increase in TNF-␣ and TNF-␣ receptor 1 expression induced activation and production of superoxide via NAD(P)H oxidase or the mitochondria respiratory chain, leading to endothelial dysfunction in coronary microcirculation and aortas. [42] [43] [44] Our results suggest that IFN-␥ treatment significantly increased the mRNA expression of TNF-␣ in the MAT of nondiabetic control mice. Recombinant TNF-␣ incubation impaired the endothelial function of SMA in control mice, suggesting the potential role of the IFN-␥-induced MAT proinflammatory status in the regulation of SMA endothelial function. Moreover, the superoxide level in the MAT of diabetic mice was significantly higher, but bariatric surgery reduced MAT superoxide production. Thus, visceral obesity-associated alterations of the vasculature are likely a consequence of perturbation of the normal physiological balance of adipose-derived inflammatory cytokines and oxidative stress, and bariatric surgery can reverse the alteration.
Bariatric Surgery Improves Endothelial Function by Inhibiting Oxidative Stress and Increasing Nitric Oxide Availability
In morbidly obese patients, bariatric surgery rapidly improved endothelial function. 45, 46 The mechanisms of bariatric surgery-induced amelioration of endothelial dysfunction are not clearly elucidated, but some studies suggest that reduction in circulating level of markers of endothelial activation and oxidative stress may serve as mechanisms. 47, 48 Our study shows that bariatric surgery remarkably improved the endothelium-dependent vasorelaxation of SMA without affecting endothelium-independent vasorelaxation and phenylephrine-induced vasoconstriction (Figure 3, Supplemental Figures V, VI) . The superoxide level and nitrotyrosine protein expression in the SMA were elevated in diabetic mice but were reversed by bariatric surgery (Figure 6 ). Although bariatric surgery improved endothelium-dependent vasorelaxation of SMA in diabetic mice, the improvement was largely attenuated by incubating the vessels with nitric oxide synthase inhibitor, L-NAME, suggesting that bariatric surgery improves endothelial function by improving nitric oxide availability (Figure 4) .
Although we observed that the SMA endothelial function of Lepr db at 5, 10, and 20 days after surgery was completely restored to the level of nondiabetic control mice, in Lepr db at 30 days post surgery, this procedure only partially improved endothelial function (Figure 3) . Moreover, the protein expression of IFN-␥ and MCP-1 in diabetic mice at 30 days after surgery slightly returned toward the level observed in the Lepr db plus sham surgery group, even though there was no significant body weight regain or hyperglycemia. We postulate that an early indicator of relapse after surgery may be characterized by the partial restoration of adipose tissue inflammation and endothelial dysfunction that precedes a regain of body weight and increased incidence of hyperglycemia over the long-term after surgery in type 2 diabetic mice. Thus, weight likely is not the determinant of endothelial dysfunction. 49, 50 The inflammatory milieu that was rapidly corrected by surgery is linked to endothelial dysfunction in diabetes.
One caveat to this study is that the mice were fairly young (3 months old) when subjected to the surgery procedure. However, because the lifespan of Lepr db mice is up to 10 months, our protocol will potentially allow the observation of long-term effects of bariatric surgical procedures. We found that the endothelial function of Lepr db at 90 days after surgery was slightly impaired compared with Lepr db at 30 days after surgery (although still better than Lepr db plus sham surgery), with a slight increase in body weight and blood glucose level (unpublished data), which highlights the need to examine the long-term effects of bariatric surgery. The long-term follow-up study of patients undergoing bariatric surgery showed that body weight reached the lowest point at Ϸ2 years and there was a significant increase in body mass index from the nadir to 5 years, and from 5 years to 10 years after surgery. 51 Thus, although bariatric surgery is a favorable option in the treatment of diabetic patients with severe obesity, discerning the benefits over time requires further evaluation. Because of the difficulties in conducting long-term follow-up studies in human subjects treated with bariatric surgery over time, our study using type 2 diabetic mice can explore a wider spectrum of interest more quickly and definitely to evaluate and refine the most relevant protocols that may be translatable to clinical studies.
Conclusion
In summary, bariatric surgery reduces body weight and whole body and abdominal adiposity, and improves glycemic control in type 2 diabetic mice. Bariatric surgery ameliorates IFN-␥-mediated MAT inflammation/oxidative stress and improves SMA endothelial function in type 2 diabetes. We posit that the vascular benefits of bariatric surgery are chiefly derived from a surgery-induced reduction in adipose tissue inflammation. These data demonstrate that the amelioration of adipose tissue inflammation and the improvement of endothelial function may represent important mechanisms that result in cardiovascular benefits after bariatric surgery.
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